Ambrosia Biosciences Funding: $141M Raised, Series B (2026)

Ambrosia Biosciences funding overview

Ambrosia Biosciences is a Biotech company based in Boulder. Ambrosia Biosciences has raised $141M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2026. The round record for Ambrosia Biosciences runs through 2026; nothing later has been disclosed. Investors on record include Blue Owl Healthcare Opportunities, Redmile, Deep Track Capital, BVF Partners, Boulder Ventures, Janus Henderson Investors and 1 others. 7 distinct backers are named across the disclosed rounds.

Ambrosia Biosciences at a glance

Total raised: $141M
Latest round: Series B
Latest round date: March 2026
Industry: Biotech
Headquarters: Boulder
Notable investors: Blue Owl Healthcare Opportunities, Redmile, Deep Track Capital, BVF Partners, Boulder Ventures, Janus Henderson Investors, Samsara BioCapital

Frequently asked about Ambrosia Biosciences funding

How much has Ambrosia Biosciences raised?: Ambrosia Biosciences has raised $141M in total disclosed funding across the rounds on record.
Who has invested in Ambrosia Biosciences?: Blue Owl Healthcare Opportunities, Redmile, Deep Track Capital, BVF Partners, Boulder Ventures, Janus Henderson Investors are named among the investors backing Ambrosia Biosciences.
What was the latest Ambrosia Biosciences funding round?: The most recent disclosed round is a Series B, announced in March 2026.
Where is Ambrosia Biosciences based?: Ambrosia Biosciences is based in Boulder.
What sector does Ambrosia Biosciences operate in?: Ambrosia Biosciences is tracked under Biotech from Boulder, with $141M in disclosed funding.
When did Ambrosia Biosciences last raise?: The last disclosed Ambrosia Biosciences round closed in March 2026 at Series B.

Round data for Ambrosia Biosciences is compiled from public filings and announcements; blank fields mean nothing has been disclosed rather than nothing exists. Continue with the Biotech companies in Boulder and backer lists below.

Ambrosia Biosciences Funding: $141M Raised, Series B (2026)

Ambrosia Biosciences funding overview

Ambrosia Biosciences at a glance

Frequently asked about Ambrosia Biosciences funding

Ambrosia Biosciences founders (1)

Companies related to Ambrosia Biosciences (40)

Browse related funding lists (6)